IOR vs NMS

IOR exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. While the stock appears undervalued based on the Graham Number ($26.13) and a Price-to-Book ratio of 0.58, these are likely value traps given the intrinsic value of $6.86 and negative growth trends. Profitability is non-existent with 0.00% profit and operating margins, coupled with a -12.20% decline in YoY earnings. The technical trend is bearish, and the lack of analyst coverage further increases the risk profile.

The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 1/9, which heavily penalizes the fund's fundamental health rating. While the fund has shown strong price appreciation over the last 1-3 years and maintains a respectable dividend yield of 6.54%, the technical trend has collapsed to 10/100, suggesting a bearish reversal. As a municipal income fund, traditional corporate metrics like the Altman Z-Score and Graham Number are not applicable, but the current price is trading at the ceiling of its 52-week range ($12.20 vs $12.25 high). The combination of poor deterministic health scores and a bearish technical outlook offsets the positive historical price performance.